Bio-Rad Laboratories | BIO - Gross Profit On Sales


Bio-Rad Laboratories reported $345.2M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Abbott USD 5.86B 675M Mar/2026
Agilent USD 990M 44M Mar/2026
Becton, Dickinson and Co. USD 2.15B 257M Mar/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 379.8M 69.4M Mar/2026
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Danaher USD 3.59B 375M Mar/2026
General Electric Aerospace USD 4.24B 439M Mar/2026
Illumina USD 721M 38M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Laboratory Of America USD 1.01B 20.6M Mar/2026
Merck USD 10.85B 2.57B Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Repligen USD 108.28M 4.45M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Siemens EUR 7.63B 471M Dec/2025
Standard Biotools USD 11.38M 1.9M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tosoh JPY 67.57B 10.89B Sep/2025
Waters USD 542M 15.42M Mar/2026